trial

Touchscreen-based Cognitive Tests in Healthy Volunteers

NCTId NCT03469089
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Unknown
Enrollment 16 (actual)
Sponsored by University of Eastern Finland
Primary completion 2018-05-16
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Unknown
Enrollment
16 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2018-03-12
Primary completion
2018-05-16
Eligibility
MALE · 20 Years · 40 Years

Interventions & indications

Drugs
Ketamine 0.58Ketamine 0.31modafinil

Sponsors

University of Eastern FinlandLead Sponsor

Investigators

1
Markus M Forsberg, PhDStudy Director

Sites

1 total
Kuopio, Finland

Facts & assertions

4 sourced
Enrollment
16
Phase
PHASE1
Primary Completion Date
2018-05-16
Status
UNKNOWN
relationships
The graph out of here
drug
Ketamine 0.58
drug
Ketamine 0.31
drug
modafinil
drug
lead_sponsor
University of Eastern Finland
company
indication
Schizophrenia
indication
Neurobehavioral Manifestations
indication
Cognitive Symptom
indication
investigator
Markus M Forsberg, PhD
person